Real-time enrollment status for this metastatic cancer clinical trial
Current Status
Suspended
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT05351294 |
| Recruiting Status | Suspended |
| Condition | Metastatic Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 156 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Rutgers, The State University of New Jersey |
| Last Updated on CT.gov | January 7, 2026 (Jan 7, 2026) |
As of March 2, 2026: Clinical trial NCT05351294 is currently suspended participants. This clinical trial study for metastatic cancer is not currently accepting new participants at 6 locations across the United States. The study is sponsored by Rutgers, The State University of New Jersey. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05351294 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05351294 was last updated Jan 7, 2026 (January 7, 2026). HelloStudys verifies this status automatically.